[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  FloatRaider [@FLOATRAIDER](/creator/twitter/FLOATRAIDER) on x XX followers Created: 2025-07-10 12:52:41 UTC $GLMD 🚨 Price at $XXXX — broke key level with power. Final catalyst July 27: licensing global rights to oral sublingual semaglutide. Small float, big upside if deal lands. Massive GLP‑1 market ahead. $SWVL $SPCB $ISPO $ETON $MASS $SVV $CING $SERV $WOK $ZCAR $CLEU $PCRX $USGO XXX engagements  **Related Topics** [$usgo](/topic/$usgo) [$pcrx](/topic/$pcrx) [$cleu](/topic/$cleu) [$zcar](/topic/$zcar) [$wok](/topic/$wok) [$cing](/topic/$cing) [$eton](/topic/$eton) [$ispo](/topic/$ispo) [Post Link](https://x.com/FLOATRAIDER/status/1943292290568421715)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
FloatRaider @FLOATRAIDER on x XX followers
Created: 2025-07-10 12:52:41 UTC
$GLMD 🚨 Price at $XXXX — broke key level with power. Final catalyst July 27: licensing global rights to oral sublingual semaglutide. Small float, big upside if deal lands. Massive GLP‑1 market ahead. $SWVL $SPCB $ISPO $ETON $MASS $SVV $CING $SERV $WOK $ZCAR $CLEU $PCRX $USGO
XXX engagements
Related Topics $usgo $pcrx $cleu $zcar $wok $cing $eton $ispo
/post/tweet::1943292290568421715